Zacks Investment Research on MSN
OM stock gains on FDA clearance for next-gen Tablo dialysis system
Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, ...
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 ...
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset″), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...
Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results